Home NDC 55648-711 Entacapone
Product NDC 55648-711
11-digit product format 556480711
Labeler code 55648
Product ID 55648-711_419accad-98ef-4290-ba9c-be6a387a0202
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Entacapone
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Wockhardt Limited
Application ANDA078941
Marketing category ANDA
Marketing start 2012-08-16
Marketing end 0000-00-00
Substance ENTACAPONE
Active strength 200 mg/1
Pharmacologic classes Catechol O-Methyltransferase Inhibitors [MoA],Catechol-O-Methyltransferase Inhibitor [EPC]
NDC exclude flag E
Listing certified through 2018-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 2 · 110 matching rows.
View current auxiliary records. · View the auxiliary file history.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A078941-001 ENTACAPONE ENTACAPONE 200MG TABLET / ORAL AB 2012-08-16
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A078941-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 42 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A078941-001 ENTACAPONE 200MG TABLET / ORAL AB 2012-08-16 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A078941-001 ENTACAPONE 200MG TABLET / ORAL AB 2012-08-16 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A078941-001 ENTACAPONE 200MG TABLET / ORAL AB 2012-08-16 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A078941-001 ENTACAPONE 200MG TABLET / ORAL AB 2012-08-16 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A078941-001 ENTACAPONE 200MG TABLET / ORAL AB 2012-08-16 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A078941-001 ENTACAPONE 200MG TABLET / ORAL AB 2012-08-16 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A078941-001 ENTACAPONE 200MG TABLET / ORAL AB 2012-08-16 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A078941-001 ENTACAPONE 200MG TABLET / ORAL AB 2012-08-16 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A078941-001 ENTACAPONE 200MG TABLET / ORAL AB 2012-08-16 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A078941-001 ENTACAPONE 200MG TABLET / ORAL AB 2012-08-16 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A078941-001 ENTACAPONE 200MG TABLET / ORAL AB 2012-08-16 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A078941-001 ENTACAPONE 200MG TABLET / ORAL AB 2012-08-16 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A078941-001 ENTACAPONE 200MG TABLET / ORAL AB 2012-08-16 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A078941-001 ENTACAPONE 200MG TABLET / ORAL AB 2012-08-16 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A078941-001 ENTACAPONE 200MG TABLET / ORAL AB 2012-08-16 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A078941-001 ENTACAPONE 200MG TABLET / ORAL AB 2012-08-16 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A078941-001 ENTACAPONE 200MG TABLET / ORAL AB 2012-08-16 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A078941-001 ENTACAPONE 200MG TABLET / ORAL AB 2012-08-16 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A078941-001 ENTACAPONE 200MG TABLET / ORAL AB 2012-08-16 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A078941-001 ENTACAPONE 200MG TABLET / ORAL AB 2012-08-16 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A078941-001 ENTACAPONE 200MG TABLET / ORAL AB 2012-08-16 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A078941-001 ENTACAPONE 200MG TABLET / ORAL AB 2012-08-16 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A078941-001 ENTACAPONE 200MG TABLET / ORAL AB 2012-08-16 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A078941-001 ENTACAPONE 200MG TABLET / ORAL AB 2012-08-16 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A078941-001 ENTACAPONE 200MG TABLET / ORAL AB 2012-08-16 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A078941-001 ENTACAPONE 200MG TABLET / ORAL AB 2012-08-16 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A078941-001 ENTACAPONE 200MG TABLET / ORAL AB 2012-08-16 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A078941-001 ENTACAPONE 200MG TABLET / ORAL AB 2012-08-16 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A078941-001 ENTACAPONE 200MG TABLET / ORAL AB 2012-08-16 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A078941-001 ENTACAPONE 200MG TABLET / ORAL AB 2012-08-16 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A078941-001 ENTACAPONE 200MG TABLET / ORAL AB 2012-08-16 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A078941-001 ENTACAPONE 200MG TABLET / ORAL AB 2012-08-16 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A078941-001 ENTACAPONE 200MG TABLET / ORAL AB 2012-08-16 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A078941-001 ENTACAPONE 200MG TABLET / ORAL AB 2012-08-16 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A078941-001 ENTACAPONE 200MG TABLET / ORAL AB 2012-08-16 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A078941-001 ENTACAPONE 200MG TABLET / ORAL AB 2012-08-16 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A078941-001 ENTACAPONE 200MG TABLET / ORAL AB 2012-08-16 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A078941-001 ENTACAPONE 200MG TABLET / ORAL AB 2012-08-16 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A078941-001 ENTACAPONE 200MG TABLET / ORAL AB 2012-08-16 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A078941-001 ENTACAPONE 200MG TABLET / ORAL AB 2012-08-16 e64feba35796…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 42 observed states.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 55648-711-01 Entacapone 30 in 1 BOTTLE TABLET, FILM COATED 30 2 55648-711-02 Entacapone 100 in 1 BOTTLE TABLET, FILM COATED 100 2 55648-711-03 Entacapone 500 in 1 BOTTLE TABLET, FILM COATED 500 2 55648-711-04 Entacapone 10 in 1 BLISTER PACK TABLET, FILM COATED 10 2 55648-711-04 Entacapone 10 in 1 CARTON TABLET, FILM COATED 10 2
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded ENTACAPONE ACTIVE INGREDIENT 4975G9NM6T ENTACAPONE TABLET, FILM COATED [WOCKHARDT LIMITED] 2 ENTACAPONE ACTIVE MOIETY 4975G9NM6T ENTACAPONE TABLET, FILM COATED [WOCKHARDT LIMITED] 2 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U ENTACAPONE TABLET, FILM COATED [WOCKHARDT LIMITED] 2 CROSCARMELLOSE SODIUM INACTIVE INGREDIENT M28OL1HH48 ENTACAPONE TABLET, FILM COATED [WOCKHARDT LIMITED] 2 D&C YELLOW NO. 10 INACTIVE INGREDIENT 35SW5USQ3G ENTACAPONE TABLET, FILM COATED [WOCKHARDT LIMITED] 2 FD&C YELLOW NO. 6 INACTIVE INGREDIENT H77VEI93A8 ENTACAPONE TABLET, FILM COATED [WOCKHARDT LIMITED] 2 HYDROGENATED COTTONSEED OIL INACTIVE INGREDIENT Z82Y2C65EA ENTACAPONE TABLET, FILM COATED [WOCKHARDT LIMITED] 2 HYPROMELLOSE 2910 (6 MPA.S) INACTIVE INGREDIENT 0WZ8WG20P6 ENTACAPONE TABLET, FILM COATED [WOCKHARDT LIMITED] 2 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 ENTACAPONE TABLET, FILM COATED [WOCKHARDT LIMITED] 2 MANNITOL INACTIVE INGREDIENT 3OWL53L36A ENTACAPONE TABLET, FILM COATED [WOCKHARDT LIMITED] 2 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 ENTACAPONE TABLET, FILM COATED [WOCKHARDT LIMITED] 2 SODIUM STARCH GLYCOLATE TYPE A POTATO INACTIVE INGREDIENT 5856J3G2A2 ENTACAPONE TABLET, FILM COATED [WOCKHARDT LIMITED] 2 TALC INACTIVE INGREDIENT 7SEV7J4R1U ENTACAPONE TABLET, FILM COATED [WOCKHARDT LIMITED] 2 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP ENTACAPONE TABLET, FILM COATED [WOCKHARDT LIMITED] 2 TRIACETIN INACTIVE INGREDIENT XHX3C3X673 ENTACAPONE TABLET, FILM COATED [WOCKHARDT LIMITED] 2
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 55648-711 ENTACAPONE TABLET, FILM COATED [WOCKHARDT LIMITED] 2 Legacy NDC, 5 package rows 20121107_b9ac99ad-7e82-4064-8c66-214ac6d1776b.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Status 55648-711-01 55648071101 30 in 1 BOTTLE Historical 55648-711-02 55648071102 100 in 1 BOTTLE Historical 55648-711-03 55648071103 500 in 1 BOTTLE Historical 55648-711-04 55648071104 10 in 1 BLISTER PACK Historical